WST West Pharmaceutical Services Inc

Price (delayed)

$358.36

Market cap

$26.27B

P/E Ratio

44.91

Dividend/share

$0.78

EPS

$7.98

Enterprise value

$25.72B

West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, ...

Highlights
The stock's price to earnings (P/E) is 8% less than its last 4 quarters average of 49.0 and 3.8% less than its 5-year quarterly average of 46.7
WST's equity is up by 7% year-on-year
West Pharmaceutical Services's quick ratio has decreased by 25% YoY and by 24% from the previous quarter
West Pharmaceutical Services's gross margin has decreased by 2.8% YoY

Key stats

What are the main financial stats of WST
Market
Shares outstanding
73.3M
Market cap
$26.27B
Enterprise value
$25.72B
Valuations
Price to book (P/B)
9.2
Price to sales (P/S)
9.03
EV/EBIT
35.49
EV/EBITDA
29.84
EV/Sales
8.72
Earnings
Revenue
$2.95B
EBIT
$724.7M
EBITDA
$862M
Free cash flow
$414.5M
Per share
EPS
$7.98
Free cash flow per share
$5.58
Book value per share
$38.94
Revenue per share
$39.7
TBVPS
$49.88
Balance sheet
Total assets
$3.83B
Total liabilities
$948.5M
Debt
$309M
Equity
$2.88B
Working capital
$1.26B
Liquidity
Debt to equity
0.11
Current ratio
2.88
Quick ratio
2.03
Net debt/EBITDA
-0.63
Margins
EBITDA margin
29.2%
Gross margin
38.3%
Net margin
20.1%
Operating margin
22.9%
Efficiency
Return on assets
15.8%
Return on equity
21.1%
Return on invested capital
28.9%
Return on capital employed
23%
Return on sales
24.6%
Dividend
Dividend yield
0.22%
DPS
$0.78
Payout ratio
9.8%

WST stock price

How has the West Pharmaceutical Services stock price performed over time
Intraday
0.29%
1 week
-0.43%
1 month
-3.28%
1 year
13.04%
YTD
1.77%
QTD
1.77%

Financial performance

How have West Pharmaceutical Services's revenue and profit performed over time
Revenue
$2.95B
Gross profit
$1.13B
Operating income
$676M
Net income
$593.4M
Gross margin
38.3%
Net margin
20.1%
The operating margin has declined by 10% year-on-year but it has increased by 4.1% since the previous quarter
WST's operating income is down by 8% YoY but it is up by 4.8% from the previous quarter
The net income has grown by 6% from the previous quarter
WST's net margin is up by 5% since the previous quarter

Growth

What is West Pharmaceutical Services's growth rate over time

Valuation

What is West Pharmaceutical Services stock price valuation
P/E
44.91
P/B
9.2
P/S
9.03
EV/EBIT
35.49
EV/EBITDA
29.84
EV/Sales
8.72
The stock's price to earnings (P/E) is 8% less than its last 4 quarters average of 49.0 and 3.8% less than its 5-year quarterly average of 46.7
WST's EPS is up by 6% since the previous quarter
WST's equity is up by 7% year-on-year
The price to book (P/B) is 6% lower than the 5-year quarterly average of 9.8 and 4.2% lower than the last 4 quarters average of 9.6
The P/S is 8% above the 5-year quarterly average of 8.4 but 2.9% below the last 4 quarters average of 9.3
West Pharmaceutical Services's revenue has increased by 2.2% YoY

Efficiency

How efficient is West Pharmaceutical Services business performance
West Pharmaceutical Services's ROE has decreased by 11% YoY but it has increased by 4.5% from the previous quarter
The company's return on assets fell by 8% YoY but it rose by 3.9% QoQ
WST's return on invested capital is down by 6% year-on-year but it is up by 4.7% since the previous quarter
WST's return on sales is up by 5% since the previous quarter

Dividends

What is WST's dividend history
DPS
$0.78
Dividend yield
0.22%
Payout ratio
9.8%
Recent dividends

Financial health

How did West Pharmaceutical Services financials performed over time
West Pharmaceutical Services's quick ratio has decreased by 25% YoY and by 24% from the previous quarter
West Pharmaceutical Services's current ratio has decreased by 22% QoQ and by 22% YoY
WST's debt is 89% smaller than its equity
The debt to equity has contracted by 8% YoY
WST's equity is up by 7% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.